Guidewires Manufacturers Need to ‘Innovate at Scale’ as End-user & Regulatory Climate Evolves: New FMI Study

Jun 19,2020 | Healthcare, Pharmaceuticals and Medical devices

FMI, an ESOMAR-certified market research and consulting firm, expects global guidewires market to reach US$ 5.9 Bn by 2030, in its latest study. According to the study, guidewires manufacturers will be hard-pressed to increase their spending on R&D, in line with regulatory evolutions and end-user demand.

Non-communicable diseases (NCDs) – namely cancer, cardiovascular diseases, diabetes, chronic respiratory diseases are at their all-time high, with 14 million people dying too young (before reaching 70).

The WHO Global NCD Action Plan 2013-2020 does follow on with recognition of primary role as well as responsibility of various governments regarding responding positively to challenge posed by NCDs and international co-operation for supporting national efforts.

A part of their action plan is bringing down all the NCDs listed above by at least 30% and render 80% availability of basic technologies/medications.

These include provision of guidewires to facilitate minimally-invasive surgical procedures at affordable rates in ambulatory centres. These factors have been collectively driving the guidewires market till date and will continue to do so in the forecast period as well. Plus, US FDA has come up with guidelines regarding upgradation of guidewires to ensure faster and more efficient procedures. This is another factor giving impetus to the market. This upgradation is likely to happen through inorganic as well as organic mode of expansion.

Again, as per FMI, the global guidewires market is slated to value US$ 3.3 Bn in 2020 and expected to witness a substantial CAGR of over 6.0% between 2020 and 2030.

For More Detailed Insights on Guidewires Market

Key Takeaways of Guidewires Market Study

  • The global guidewires market, in the year 2019, was dominated by interventional guidewires as they continue to be the first choice with regards to minimally-invasive surgical procedures
  • As far as applications are concerned, peripheral and coronary guidewires collectively account for around 65% of revenue share
  • By material, stainless steel, due to superior torque and ductility, is expected to be the highest revenue generator in the forecast period.
  • North America is expected to be the most lucrative region and expected to generate around 40% of the overall revenue in 2020 and this trend is expected to continue during the forecast period.

“Technological advancements such as the development of multifunctional and low-cost guidewires are expected to provide an innovative paradigm shift to market players.” Says the FMI Analyst.

New Product Launches – The Win-Win Strategy for Market Players

The market players are focusing on launching advanced products for supporting clinicians with respect to interventional or diagnostic procedures. For instance – Olympus Corporation, in May 2019, tabled RevoWave endoscopic guidewire in the U.S. for performing balloon dilation, biliary endoscopy, and stent placement. On the similar grounds, Abbott’s Frontline Workhorse guidewires are making ways for most interventional devices.

What else is in the report?

Future Market Insights offers actionable insights and unique perspective on guidewires market in its latest study, presenting historical demand assessment from 2015 – 2019 and projections from 2020–2030 based on product type (interventional guidewires and diagnostic guidewires), by application (coronary guidewires, peripheral guidewires, urology guidewires, radiology guidewires, neurovascular guidewires, gastroenterology guidewires and others) by material type (Nitinol guidewires, PTFE guidewires, stainless steel guidewires and hybrid guidewires) by tip shape (J tip, angled tip and straight tip) by end-user (hospitals, ambulatory surgical centres, cardiac catheterization laboratories and speciality clinics) in seven key regions.

About the Healthcare Research Practice at Future Market Insights

Future Market Insights enables corporates, governments, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you to devise innovation-driven trajectories for your business. Know more about our sector coverage here

About Healthcare division of FMI

The Healthcare team at Future Market Insights has consistently tracked and analyzed rapidly evolving trends and developments in the global healthcare industry, encompassing pharmaceuticals and medical devices markets. The team facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously track emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Media Contact

Rahul Pandita

Rahul Pandita

Head – Corporate Communications

Abhishek Budholiya

Abhishek Budholiya

Head – Digital Marketing